Agenus Inc (AGEN)

Agenus Inc (AGEN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $273M; returns 1 day -2.8%, 1 week +4.8%, 1 year +51.4%.

Agenus Inc. is a clinical-stage immuno-oncology company specializing in the development of next-generation antibody therapeutics, vaccine adjuvants, and adoptive cell therapies.

Groups AGEN belongs to

• Clinical Stage Biotech
• Biotechnology
• Oncology
• Immunotherapy
• Antibody Therapeutics
• Healthcare
• Cancer Therapeutics
• Life Sciences
• Biopharmaceutical
• Clinical Stage
• Royalty Streams

AGEN financial model: income statement, cash flow and balance sheet